Stock listing

NASDAQ:CLPT ClearPoint Neuro Inc. Stock

Home listing (NASDAQ) of ClearPoint Neuro Inc.

Follow ClearPoint Neuro Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CLPT

$6.91 USD -0.80 (-10.4%)

Close on Nov 20, 2026

Past year -48.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.85 – $7.45 USDNov 20, 2026
Volume
1.11M sharesNov 20, 2026
Market cap
$221.5M USDAt the close on Nov 20, 2026 · price × 32.05M shares outstanding
52-week range
$6.85 – $19.63 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$8.01M USDMedian day 640,195 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ClearPoint Neuro Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CLPT · Home$6.91 USD-0.80 (-10.4%)1,108,673$7.15$7.445$6.85$7.71Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CLPT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.91-0.80-10.4%$7.15$7.445$6.851,108,673
$7.71-0.15-1.9%$7.92$8.05$7.60638,967
$7.86-0.44-5.3%$8.18$8.30$7.812640,195
$8.30-0.18-2.1%$8.32$8.48$8.115973,409
$8.48-0.01-0.1%$8.56$8.57$8.31505,605
$8.49-0.68-7.4%$8.905$9.08$8.38703,017
$9.17+0.40+4.6%$8.98$9.24$8.89440,260
$8.77-0.40-4.4%$8.99$9.29$8.76425,795
$9.17+0.57+6.6%$8.65$9.40$8.65479,051
$8.60-0.09-1.0%$8.81$8.82$8.27945,854
$8.69-1.47-14.5%$10.16$10.16$8.461,300,639
$10.16+0.45+4.6%$10.00$10.38$10.00673,810
$9.71-0.24-2.4%$10.01$10.18$9.53783,887
$9.95-0.72-6.7%$11.24$11.30$9.91707,314
$10.67-0.02-0.2%$10.69$10.80$10.00915,403
$10.69+0.13+1.2%$10.86$11.97$10.651,249,798
$10.56+0.87+9.0%$9.59$10.75$9.58863,762
$9.69+0.65+7.2%$9.05$9.77$9.00752,938
$9.04-0.10-1.1%$9.17$9.17$8.91455,576
$9.14-0.11-1.2%$9.19$9.22$8.95355,472
$9.250.000.0%$9.30$9.43$9.06448,647
$9.25-0.20-2.1%$9.47$9.58$9.22410,531
$9.45+0.28+3.1%$9.27$9.72$9.192468,179
$9.17+0.10+1.1%$9.11$9.22$8.95481,029
$9.07-0.57-5.9%$9.58$9.60$9.00965,000
$9.64+0.40+4.3%$9.11$9.68$9.10797,600
$9.24-0.57-5.8%$9.68$9.80$9.191,012,700
$9.81-0.39-3.8%$10.17$10.17$9.72792,300
$10.20-0.28-2.7%$10.37$10.51$10.12397,600
$10.48-0.01-0.1%$10.45$10.60$10.22409,500
$10.49-0.17-1.6%$10.56$10.56$10.18717,900
$10.66-0.35-3.2%$10.85$10.98$10.58490,100
$11.01-0.51-4.4%$11.60$11.74$10.63903,500
$11.52+0.62+5.7%$10.85$11.53$10.61760,000
$10.90-0.55-4.8%$11.58$11.58$10.85831,500
$11.45-0.76-6.2%$12.24$12.24$11.40765,900
$12.21+0.44+3.7%$11.85$12.54$11.541,253,700
$11.77-3.54-23.1%$12.63$12.99$11.602,693,800
$15.31+0.48+3.2%$14.64$15.42$14.24476,200
$14.83+0.22+1.5%$14.77$15.12$14.36321,300
$14.61-0.36-2.4%$14.82$14.90$14.23669,800
$14.97-0.82-5.2%$15.55$15.83$14.53574,000
$15.79+1.82+13.0%$14.00$16.49$14.001,142,100
$13.97+0.14+1.0%$13.96$14.13$13.71373,400
$13.83+0.09+0.7%$13.67$13.92$13.57525,600
$13.74+0.34+2.5%$13.65$13.87$13.42477,100
$13.40+0.25+1.9%$13.16$13.50$13.13382,000
$13.15-0.31-2.3%$13.45$13.50$12.99642,800
$13.46-0.26-1.9%$13.53$13.94$13.45478,900
$13.72+0.24+1.8%$13.65$13.89$13.311,021,400
$13.48-0.40-2.9%$13.57$13.76$13.31404,200
$13.88-0.17-1.2%$13.94$14.11$13.80450,100
$14.05+0.09+0.6%$13.60$14.22$13.44746,400
$13.96-0.09-0.6%$14.00$14.09$13.78384,900
$14.05-0.26-1.8%$14.33$14.76$13.84640,600
$14.31-0.59-4.0%$15.54$15.98$14.27803,800
$14.90-0.24-1.6%$15.11$15.30$14.46809,300
$15.14-0.41-2.6%$15.56$15.57$15.06414,600
$15.55-0.39-2.4%$15.73$16.08$15.44467,500
$15.94-0.43-2.6%$16.28$16.78$15.91440,400
$16.37-0.59-3.5%$16.85$16.99$16.18505,500
$16.96+1.79+11.8%$15.28$17.22$15.241,081,430
$15.17-0.22-1.4%$15.40$15.44$14.65422,072
$15.39+0.20+1.3%$15.13$15.53$14.97560,500
$15.19-0.77-4.8%$15.77$16.08$15.18398,100

Splits

1 split · NASDAQ:CLPT · every price before a split is adjusted for it

DayRatioWhat
1-for-40Consolidation
Ticker
NASDAQ:CLPT
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All ClearPoint Neuro Inc. news

ClearPoint Neuro Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
16 in the last 12 months · 152 in all · newest Oct 28, 2026 · oldest 2020
Calls
27 calls with a replay · 27 with a transcript · latest Oct 28, 2026
Decks
61 decks · latest Oct 28, 2026

Where ClearPoint Neuro Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CLPT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CLPTBOATSUnited StatesUSD

Valuation

EV/sales 5.0× against a median of 3.4×: 8th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$226.2M USD
P/E
Loss
EV/sales
5.0×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
8.1×
Gross margin
61.4%
Operating margin
−70.6%
Net margin
−79.4%
Debt to equity
1.9×
Beta vs S&P 500
1.97

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ClearPoint Neuro Inc. · NASDAQ:CLPTUS$221.5MUS$226.2Mn/a5.0×n/a8.1×−79.4%1.9×1.97
Profound Medical Corp · TSX:PRNUS$235.5MUS$206.6Mn/a8.8×n/a5.5×−137.5%0.1×1.19
Jiangsu Nanfang Medical Co., Ltd. Class A · SSE:603880US$232.0MUS$233.5Mn/a2.8×n/a10.4×−18.9%0.3×n/a
Jenscare Scientific Co. Ltd. Class H · HKEX:9877US$224.5MUS$168.3Mn/a12.7×n/a2.0×−299.4%0.1×n/a
Utah Medical Products, Inc. · NASDAQ:UTMDUS$220.6MUS$135.6M20.7×3.9×n/a1.8×30.5%0.0×0.31
JVM Co., Ltd. · KRX:054950US$219.0MUS$106.5M9.6×0.8×3.4×1.2×17.4%0.0×n/a
Bioteque Corporation · TPEX:4107US$217.6MUS$163.2M12.2×2.4×6.0×2.0×26.5%0.0×n/a
Stille AB · OMXSTO:STILUS$217.5MUS$200.8M23.1×2.9×n/a2.8×13.5%0.0×n/a
Touchstone International Medical Science Co. Ltd. Class A · SSE:688013US$216.1MUS$180.6M50.4×4.7×n/a2.9×11.2%0.1×n/a
Won Tech Co.,Ltd. · KRX:336570US$213.0MUS$147.6M7.2×1.2×4.4×1.7×23.9%0.2×n/a
Spectral Medical Inc · TSX:EDTUS$210.9MUS$228.2Mn/a127×n/an/an/an/a0.51
Median of the othersUS$218.3MUS$174.4M16.4×3.4×4.4×2.0×13.5%0.1×0.51

Forecasts

2 strong buy · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
21.50 USD · Analysts' mean
EPS, year to Dec 2026
-1.17 · 2 analysts
Revenue, year to Dec 2026
48.5M · 2 analysts

Team and board

Officers

OfficerRole
Joseph M. BurnettPresident & CEO
Danilo D’AlessandroChief Financial Officer
Mazin SabraChief Operating Officer
Chris YelleyVice President of Strategic Operations
Ernesto SalegioVice President, Segment Leader Translational & Pre-Clinical Research
Lyubomir ZagorchevVice President of Clinical Science & Applications
Mary McNamara-CullinaneVice President of Regulatory Affairs
Megan FaulkenberryVice President of Quality
Rob KornSenior Vice President of Sales & Business Development
Timothy OrrVice President of Software Development
Jeremy StigallChief Business Officer
Paul S. LarsonChief Medical Officer

Board

DirectorRole
R. John FletcherChairman of the Board
B. Kristine JohnsonDirector
Joseph M. BurnettPresident & CEO
Linda M. LiauDirector
Lynnette C. FallonDirector
Matthew KleinDirector
Timothy T. RichardsDirector

Events

Calls

CallWhenStatus
ClearPoint Neuro (NASDAQ:CLPT) Q3 2026 Earnings CallWed, Oct 28, 2026 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2026 Earnings CallMon, Aug 03, 2026 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q1 2026 Earnings CallWed, May 13, 2026 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2025 Earnings CallTue, Mar 17, 2026 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2025 Earnings CallThu, Nov 06, 2025 · 5:00 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2025 Earnings CallTue, Aug 12, 2025 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q1 2025 Earnings CallTue, May 13, 2025 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2024 Earnings CallWed, Feb 26, 2025 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2024 Earnings CallThu, Nov 07, 2024 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2024 Earnings CallWed, Aug 07, 2024 · 4:30 PM ETReplay
All 27 calls
CallWhenStatus
ClearPoint Neuro (NASDAQ:CLPT) Q1 2024 Earnings CallTue, May 07, 2024 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2023 Earnings CallTue, Mar 12, 2024 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2022 Earnings CallWed, Mar 01, 2023 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2022 Earnings CallTue, Aug 09, 2022 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q1 2022 Earnings CallWed, May 11, 2022 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2021 Earnings CallTue, Mar 01, 2022 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2021 Earnings CallTue, Aug 10, 2021 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q1 2021 Earnings CallTue, May 11, 2021 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2020 Earnings CallThu, Mar 04, 2021 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q3 2020 Earnings CallWed, Nov 11, 2020 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q2 2020 Earnings CallWed, Aug 12, 2020 · 4:30 PM ETReplay
ClearPoint Neuro (NASDAQ:CLPT) Q4 2019 Earnings CallWed, Feb 12, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 28, 2026 · After close+1.2%
Q2 2026Aug 3, 2026 · After close−16.3%
Q1 2026May 13, 2026 · After close+4.8%
Q4 2025Mar 4, 2026+4.6%
Q3 2025Nov 6, 2025 · After close−13.3%
Q2 2025Aug 12, 2025 · After close+13.1%
Q1 2025May 13, 2025 · After close−12.5%
Q4 2024Feb 26, 2025−15.0%
Q3 2024Nov 7, 2024 · After close−13.2%
Q2 2024Aug 7, 2024 · After close+40.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close+1.7%
Q4 2023Mar 12, 2024 · After close+18.5%
Q3 2023Nov 9, 2023 · After close−17.7%
Q2 2023Aug 8, 2023 · After close−2.8%
Q1 2023May 11, 2023 · After close−1.6%
Q4 2022Mar 1, 2023 · After close−9.8%
Q3 2022Nov 8, 2022 · After close−5.4%
Q2 2022Aug 9, 2022 · After close+13.6%
Q1 2022May 11, 2022 · After close+9.2%
Q4 2021Mar 1, 2022 · After close+2.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck26 slidesOct 28, 2026
Q2 2026 Earnings PresentationEarnings26 slidesAug 3, 2026
Investor Presentation (May 2026)Investor deck26 slidesMay 13, 2026
Q1 2026 Earnings PresentationEarnings8 slidesMay 13, 2026
Investor Presentation (March 2026)Investor deck26 slidesMar 17, 2026
Q4 2025 Earnings PresentationEarnings26 slidesMar 17, 2026
Presentation (February 2026)10 slidesFeb 5, 2026
Investor Presentation (November 2025)Investor deck31 slidesNov 6, 2025
Investor Presentation (August 2025)Investor deck31 slidesAug 12, 2025
Investor Presentation (May 2025)Investor deck31 slidesMay 13, 2025
Show 50 decks
DeckKindSlidesDate
Investor Presentation (February 2025)Investor deck31 slidesFeb 26, 2025
Investor Presentation (November 2024)Investor deck18 slidesNov 7, 2024
Investor Presentation (August 2024)Investor deck18 slidesAug 7, 2024
Investor Presentation (May 2024)Investor deck18 slidesMay 7, 2024
Investor Presentation (March 2024)Investor deck18 slidesMar 12, 2024
J.P. Morgan Healthcare Conference 2024Conference18 slidesJan 8, 2024
Q3 2023 Earnings PresentationEarnings20 slidesNov 9, 2023
Investor Presentation (August 2023)Investor deck20 slidesAug 8, 2023
Investor Presentation (May 2023)Investor deck20 slidesMay 11, 2023
Investor Presentation (January 2023)Investor deck19 slidesJan 11, 2023
Investor Presentation (November 2022)Investor deck19 slidesNov 8, 2022
Investor Presentation (August 2022)Investor deck19 slidesAug 9, 2022
Investor Presentation (May 2022)Investor deck19 slidesMay 11, 2022
Investor Presentation (February 2022)Investor deck19 slidesFeb 15, 2022
Investor Presentation (November 2021)Investor deck28 slidesNov 9, 2021
Investor Presentation (August 2021)Investor deck28 slidesAug 10, 2021
Investor Presentation (May 2021)Investor deck28 slidesMay 25, 2021
Investor Presentation (May 2021)Investor deck27 slidesMay 12, 2021
Investor Presentation (April 2021)Investor deck13 slidesApril 2021
Investor Presentation (February 2021)Investor deck27 slidesFeb 19, 2021
Investor Presentation (November 2020)Investor deck35 slidesNov 10, 2020
Investor Presentation (August 2020)Investor deck35 slidesAug 12, 2020
Investor Presentation (May 2020)Investor deck35 slidesMay 20, 2020
Investor Presentation (February 2020)Investor deck35 slidesFeb 14, 2020
MRI Interventions — Investor Presentation (December 2019)Investor deck16 slidesDec 9, 2019
MRI Interventions — Investor Presentation (August 2019)Investor deck22 slidesAug 28, 2019
MRI Interventions — Investor Presentation (March 2019)Investor deck21 slidesMar 11, 2019
MRI Interventions — Investor Presentation (September 2018)Investor deck23 slidesSep 27, 2018
MRI Interventions — Investor Presentation (June 2018)Investor deck23 slidesJun 5, 2018
MRI Interventions — Investor Presentation (April 2018)Investor deck25 slidesApr 10, 2018
MRI Interventions — Investor Presentation (December 2017)Investor deck21 slidesDec 6, 2017
MRI Interventions — Investor Presentation (November 2017)Investor deck25 slidesNov 6, 2017
MRI Interventions — Investor Presentation (October 2017)Investor deck27 slidesOct 3, 2017
MRI Interventions — Investor Presentation (August 2017)Investor deck27 slidesAug 1, 2017
MRI Interventions — Investor Presentation (May 2017)Investor deck27 slidesMay 1, 2017
MRI Interventions — Investor Presentation (February 2017)Investor deck23 slidesFeb 28, 2017
MRI Interventions — Investor Presentation (November 2016)Investor deck23 slidesNov 4, 2016
MRI Interventions — Investor Presentation (August 2016)Investor deck22 slidesAug 18, 2016
MRI Interventions — LD Micro Invitational 2016Conference25 slidesJun 9, 2016
MRI Interventions — Investor Presentation (June 2016)Investor deck27 slidesJun 9, 2016

This page holds 50 of 61 decks. Open Decks

Open Decks

Financings

RaiseDate
Notes
Tranche closed: US$30M raised
Buyers: Oberland Capital Management LLC (note financing of up to $105 Million, with $30.0 million funded at closing)
Use of proceeds: General corporate purposes, which may include capital expenditures, working capital, and general and administrative expenses
May 12, 2025
Registered direct offering of common stock
Closed: US$3.5M raised · US$12.69 a share
Buyers: Oberland Capital (275,808 shares for $3,500,003.52)
Use of proceeds: General corporate purposes, which may include capital expenditures, working capital, and general and administrative expenses
May 12, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue37.0M31.4M24.0M20.6M16.3M12.8M11.2M7.35M7.38M5.75M
Cost of revenue14.3M12.3M10.3M7.02M5.18M3.71M3.94M2.43M2.90M2.64M
Gross profit22.7M19.1M13.6M13.5M11.1M9.12M7.28M4.92M4.48M3.11M
Research and development13.9M12.4M11.7M10.9M9.28M4.69M2.81M2.31M2.81M2.63M
Selling, general and administrative16.5M12.0M11.8M9.61M8.00M5.27M4.30M4.33M4.05M4.19M
Operating income-24.2M-19.7M-22.4M-16.3M-13.4M-6.22M-4.59M-5.25M-6.34M-7.49M
Depreciation and amortization814.0K980.0K626.0K244.0K159.0K334.0K144.0K109.4K116.5K155.7K
EBITDA-23.4M-18.8M-21.8M-16.1M-13.2M-5.89M-4.45M-5.14M-6.22M-7.33M
Interest expense2.39M518.0K81.0K973.0K1.44M955.0K980.4K872.9K1.05M
Income before tax-25.5M-18.9M
Income tax55.0K12.0K8.00K000
Net income-25.5M-18.9M-22.1M-16.4M-14.4M-6.78M-5.54M-6.16M-7.17M-8.07M
Earnings per share, basic-0.90-0.70-0.90-0.68-0.69-0.43-0.42-0.56-0.93-2.93
Earnings per share, diluted-0.90-0.70-0.90-0.68-0.69-0.43-0.42-0.56-0.93-2.93

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents45.9M20.1M23.1M27.6M54.1M20.1M5.70M3.10M9.29M3.32M
Short-term investments09.87M0
Receivables6.55M4.71M3.21M2.67M2.34M1.88M1.09M1.23M949.4K865.9K
Inventory8.36M6.86M7.91M9.30M4.94M3.24M3.24M2.11M2.31M1.77M
Current assets63.6M33.4M36.2M51.2M61.9M25.5M10.4M6.65M12.7M6.09M
Property, plant and equipment2.62M2.00M1.39M806.0K539.0K319.0K447.0K377.7K267.7K328.2K
Goodwill7.47M7.47M
Total assets97.7M39.2M42.7M55.5M65.6M29.5M11.9M7.86M13.9M7.40M
Accounts payable1.26M1.34M393.0K272.0K427.0K300.0K966.0K500.9K759.4K1.55M
Current liabilities10.8M10.4M7.43M6.79M4.75M3.20M3.83M1.87M4.40M3.02M
Total debt49.1M9.95M9.89M9.84M21.3M2.07M3.48M4.92M4.49M
Total liabilities69.7M13.8M21.5M18.6M16.8M27.1M7.34M6.35M8.07M8.16M
Shareholders' equity28.0M25.4M21.2M36.9M48.8M2.38M4.59M1.51M5.83M-756.1K
Shares outstanding29.4M27.6M24.7M24.6M23.7M17.0M15.2M11.0M10.7M3.62M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-23.9M-8.95M-13.7M-16.2M-12.7M-7.81M-2.85M-4.63M-5.99M-5.82M
Capital spending-522.0K-275.0K-717.0K-253.0K-168.0K-41.0K-10.0K-63.5K-26.8K-101.0K
Free cash flow-24.4M-9.22M-14.4M-16.4M-12.9M-7.85M-2.86M-4.69M-6.02M-5.92M
Cash from investing615.0K-275.0K8.95M-10.7M-168.0K-482.0K-160.0K-63.5K-26.8K-101.0K
Cash from financing50.2M6.19M296.0K409.0K46.9M22.7M5.61M-1.49M12.0M3.83M
Change in cash26.9M-3.04M-4.47M-26.5M34.0M14.4M2.60M-6.19M5.97M-2.09M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 18, 2026Material contractSEC
S-3 · Registration statementNov 18, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 3, 2026Big-stake noticeSEC
10-Q · Quarterly reportOct 28, 2026Quarterly reportSEC
8-K · Current reportOct 28, 2026ResultsSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportAug 3, 2026Quarterly reportSEC
8-K · Current reportAug 3, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 27, 2026Big-stake noticeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
144 · Notice of proposed saleJun 17, 2026Other filingsSEC
144 · Notice of proposed saleJun 17, 2026Other filingsSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
8-K · Current reportMay 21, 2026Management or board changeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
S-8 · Registration statement for employee plansMay 20, 2026Offer documentSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
8-K · Current reportMay 13, 2026ResultsSEC
ARS · Annual report to shareholdersApr 23, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 23, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 20, 2026Big-stake noticeSEC
DEF 14A · Proxy statementApr 10, 2026Meeting noticeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
10-K · Annual reportMar 17, 2026Annual reportSEC
8-K · Current reportMar 17, 2026ResultsSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMar 13, 2026Big-stake noticeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 25, 2026Other filingsSEC
144/A · Notice of proposed sale, amendedFeb 20, 2026Other filingsSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 9, 2026Offer documentSEC
8-K/A · Current report, amendedFeb 5, 2026Current reportSEC
DFeb 5, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2026Big-stake noticeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
UPLOAD · Letter from the SECJan 27, 2026Other filingsSEC
144 · Notice of proposed saleJan 26, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveJan 23, 2026Other filingsSEC
424B3 · ProspectusJan 22, 2026Offer documentSEC
CORRESP · Letter to the SECJan 20, 2026Other filingsSEC
S-3 · Registration statementJan 14, 2026Offer documentSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026ResultsSEC
144 · Notice of proposed saleJan 9, 2026Other filingsSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
8-K · Current reportJan 5, 2026Material contractSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
8-K · Current reportNov 20, 2025Acquisition or disposalSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
8-K · Current reportNov 6, 2025Material contractSEC
4 · Change in ownershipOct 14, 2025Insider tradeSEC
4 · Change in ownershipOct 14, 2025Insider tradeSEC
144 · Notice of proposed saleOct 10, 2025Other filingsSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
S-8 · Registration statement for employee plansSep 4, 2025Offer documentSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJul 29, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJul 17, 2025Big-stake noticeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
8-K · Current reportJun 17, 2025Material contractSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
144 · Notice of proposed saleJun 10, 2025Other filingsSEC
144 · Notice of proposed saleJun 9, 2025Other filingsSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
144 · Notice of proposed saleJun 3, 2025Other filingsSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
8-K · Current reportMay 23, 2025Management or board changeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
8-K · Current reportMay 19, 2025Current reportSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
424B5 · ProspectusMay 12, 2025Offer documentSEC
8-K · Current reportMay 12, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 9, 2025Big-stake noticeSEC
DEF 14A · Proxy statementApr 9, 2025Meeting noticeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
10-K · Annual reportFeb 26, 2025Annual reportSEC
8-K · Current reportFeb 26, 2025ResultsSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 29, 2025Big-stake noticeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
8-K · Current reportNov 7, 2024Material contractSEC
424B5 · ProspectusNov 7, 2024Offer documentSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
4 · Change in ownershipOct 11, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from ClearPoint Neuro Inc.’s releases · as of Oct 21, 2026

Common shares
32,054,268
Fully diluted
32,054,268

Fully diluted

LineSharesAs of
Common shares32,054,268Oct 21, 2026

Share count over time

CountShares
Oct 21, 202632,054,268

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Mak Capital One LLC2.57M8.0%US$31.3MSep 30, 2026
BlackRock2.15M6.7%US$26.2MSep 30, 2026
Vanguard1.65M5.2%US$20.2MSep 30, 2026
State Street876K2.7%US$10.7MSep 30, 2026
Geode Capital742K2.3%US$9.06MSep 30, 2026
UBS561K1.7%US$6.85MSep 30, 2026
Marshall Wace, LLP533K1.7%US$6.51MSep 30, 2026
Lane Generational LLC443K1.4%US$5.41MSep 30, 2026
Goldman Sachs350K1.1%US$4.28MSep 30, 2026
Brown Advisory Inc326K1.0%US$3.98MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Pekin Hardy Strauss, Inc.278K0.87%US$3.39MSep 30, 2026
Compass Financial Management LLC253K0.79%US$3.09MSep 30, 2026
Millennium242K0.75%US$2.95MSep 30, 2026
Northern Trust230K0.72%US$2.8MSep 30, 2026
Diametric Capital, LP225K0.70%US$2.75MSep 30, 2026
Bank of America195K0.61%US$2.38MSep 30, 2026
Susquehanna193K0.60%US$2.35MSep 30, 2026
Trexquant Investment LP188K0.59%US$2.29MSep 30, 2026
Pier Capital, LLC178K0.55%US$2.17MSep 30, 2026
CM Management, LLC175K0.55%US$2.14MSep 30, 2026
BNY154K0.48%US$1.88MSep 30, 2026
Longaeva Partners L.P.151K0.47%US$1.84MSep 30, 2026
Parsons Capital Management Inc149K0.46%US$1.82MSep 30, 2026
Morgan Stanley148K0.46%US$1.81MSep 30, 2026
Taylor Frigon Capital Management LLC123K0.38%US$1.51MSep 30, 2026
DWS112K0.35%US$1.36MSep 30, 2026
Exome Asset Management LLC110K0.34%US$1.35MSep 30, 2026
Financial Engines Advisors L.L.C.105K0.33%US$1.28MSep 30, 2026
Schwab89,9950.28%US$1.1MSep 30, 2026
Conway Capital Management, Inc.87,9750.27%US$1.07MSep 30, 2026
Quantinno Capital Management LP83,5250.26%US$1.02MSep 30, 2026
Jane Street82,8280.26%US$1.01MSep 30, 2026
Citadel81,9910.26%US$1MSep 30, 2026
Quadrature Capital Ltd77,6930.24%US$949KSep 30, 2026
Nuveen77,0830.24%US$941KSep 30, 2026
LPL Financial LLC74,3910.23%US$908KSep 30, 2026
Corient Private Wealth LP68,5260.21%US$837KSep 30, 2026
IMC-Chicago, LLC66,4480.21%US$811KSep 30, 2026
Prelude Capital Management, LLC65,8000.21%US$803KSep 30, 2026
Citigroup Inc63,9600.20%US$781KSep 30, 2026
Commonwealth Equity Services, LLC61,0330.19%US$745KSep 30, 2026
Massar Capital Management, LP50,2780.16%US$614KSep 30, 2026
Freshford Capital Management, LLC50,0000.16%US$611KSep 30, 2026
Navellier & Associates Inc50,0000.16%US$611KSep 30, 2026
Mercer Global Advisors Inc43,6820.14%US$533KSep 30, 2026
Barclays36,4530.11%US$445KSep 30, 2026
Silvercrest Asset Management Group LLC35,7000.11%US$436KSep 30, 2026
T. Rowe Price34,8560.11%US$426KSep 30, 2026
Rhumbline Advisers34,6640.11%US$423KSep 30, 2026
Numerai GP LLC30,8440.10%US$377KSep 30, 2026

This page holds 50 of 122 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund854K2.7%US$15.2MJun 30, 2026
iShares Russell 2000 ETF737K2.3%US$13.1MJun 30, 2026
Vanguard Extended Market Index Fund352K1.1%US$6.28MJun 30, 2026
Fidelity Small Cap Index Fund309K0.96%US$4.61MJul 31, 2026
iShares Russell 2000 Growth ETF265K0.83%US$4.72MJun 30, 2026
Fidelity Extended Market Index Fund155K0.48%US$1.96MMay 31, 2026
Vanguard Russell 2000 Index Fund142K0.44%US$1.8MMay 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF123K0.38%US$2.19MJun 30, 2026
iShares Micro-Cap ETF94,7700.30%US$1.69MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF90,0780.28%US$1.61MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Schwab Small-Cap Index Fund68,5970.21%US$1.02MJul 31, 2026
DWS Global Small Cap Fund59,5420.19%US$890KJul 31, 2026
Fidelity Total Market Index Fund53,8030.17%US$682KMay 31, 2026
Master Small Cap Index Series52,6950.16%US$940KJun 30, 2026
Fidelity Series Total Market Index Fund45,2910.14%US$574KMay 31, 2026
BlackRock Advantage Small Cap Growth Fund42,9450.13%US$766KJun 30, 2026
Nuveen Small Cap Blend Index Fund37,2990.12%US$557KJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF34,3430.11%US$613KJun 30, 2026
Taylor Frigon Core Growth Fund32,2630.10%US$409KMay 31, 2026
EQ/2000 Managed Volatility Portfolio30,6030.10%US$546KJun 30, 2026
Nuveen Equity Index Fund28,5320.09%US$426KJul 31, 2026
Fidelity Small Cap Growth Index Fund26,4130.08%US$471KJun 30, 2026
Vanguard Russell 2000 Growth Index Fund26,0810.08%US$330KMay 31, 2026
DWS Global Small Cap VIP22,9280.07%US$409KJun 30, 2026
Dunham Small Cap Growth Fund22,8850.07%US$342KJul 31, 2026
Schwab Total Stock Market Index Fund21,3690.07%US$319KJul 31, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF18,2630.06%US$231KMay 31, 2026
Fidelity Nasdaq Composite Index Fund17,9310.06%US$227KMay 31, 2026
LVIP State Street Small-Cap Index Fund17,9000.06%US$319KJun 30, 2026
Fidelity ZERO Total Market Index Fund16,4080.05%US$245KJul 31, 2026
Vanguard Balanced Index Fund15,1760.05%US$271KJun 30, 2026
Small Cap Index Fund14,0710.04%US$251KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund13,7640.04%US$246KJun 30, 2026
EQ/Small Company Index Portfolio13,7000.04%US$244KJun 30, 2026
Global X Russell 2000 ETF13,4510.04%US$201KJul 31, 2026
Vanguard Institutional Total Stock Market Index Fund11,9530.04%US$213KJun 30, 2026
T. Rowe Price Extended Equity Market Index Fund11,4000.04%US$203KJun 30, 2026
Fidelity ZERO Extended Market Index Fund11,1330.03%US$166KJul 31, 2026
iShares Russell 3000 ETF10,6870.03%US$191KJun 30, 2026
Small Cap Index Fund10,4760.03%US$133KMay 31, 2026
State Street Small/Mid Cap Equity Index Portfolio10,2000.03%US$182KJun 30, 2026
EQ/AB Small Cap Growth Portfolio9,4000.03%US$168KJun 30, 2026
ATM Small Cap Managed Volatility Portfolio9,2130.03%US$164KJun 30, 2026
MetLife Russell 2000 Index Portfolio8,4610.03%US$151KJun 30, 2026
Small-Cap Index Portfolio8,3860.03%US$150KJun 30, 2026
Diversified Equity Alpha Master Portfolio7,3070.02%US$130KJun 30, 2026
1290 VT Micro Cap Portfolio6,3220.02%US$113KJun 30, 2026
Invesco NASDAQ Future Gen 200 ETF6,1140.02%US$77,464May 31, 2026
NVIT Small Cap Index Fund5,9590.02%US$106KJun 30, 2026
Small Cap Index Trust5,8060.02%US$104KJun 30, 2026

This page holds 50 of 98 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Burnett Joseph
Director, Officer: CEO and President
Sale20,000USD 19.38US$388KJun 29, 2026
Burnett Joseph
Director, Officer: CEO and President
Sale60,000USD 17.79US$1.07MJun 17, 2026
Burnett Joseph
Director, Officer: CEO and President
Sale1,843USD 17.94US$33,063Jun 17, 2026
Richards Timothy T.
Director
Sale5,415USD 12.17US$65,901Jun 1, 2026
Klein Matthew B.
Director
Sale16,000USD 11.59US$185KMay 21, 2026
Fallon Lynnette C
Director
Sale5,091USD 11.14US$56,714May 20, 2026

Big stakes

StakeStakeSharesDateFiling
Bigger Michael8.12%2.6MSep 30, 2026Schedule 13G
Mak Capital One LLC7.80%2.38MJun 30, 2026Schedule 13G
BlackRock, Inc.7.10%2.12MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Maria Sainz
Other companies: Pulse Biosciences, Inc (Board Member · Since at least Jan 8, 2026); Hyperfine, Inc. (President and CEO · Since at least Dec 22, 2021); ATRION Corporation (Director · Aug 30, 2021 – May 24, 2022 · Past); Shockwave Medical Inc (Director · Jul 16, 2020 – May 31, 2024 · Past); Avanos Medical, Inc. (Director · Jan 2, 2019 – Jan 3, 2022 · Past); IRIDEX Corporation (Director · Apr 13, 2018 – Jul 23, 2019 · Past); Halyard Health Inc (Director · Feb 2, 2015 – May 3, 2018 · Past); The Spectranetics Corp (Director · Nov 1, 2010 – Aug 9, 2017 · Past); Orthofix Medical Inc. (Director · Jun 19, 2008 – Jun 8, 2020 · Past); Guidant Corp (President, Cardiac Surgery · Mar 31, 2006 – Apr 21, 2006 · Past)
Director · Jan 1, 2014 – Mar 30, 2018 · Past
B. Kristine Johnson
Other companies: AtriCure, Inc. (Director · Since at least Mar 21, 2017); Paragon 28 Inc (Director · Dec 1, 2021 – Apr 21, 2025 · Past); The Spectranetics Corp (Director · May 31, 2012 – Aug 9, 2017 · Past); Piper Sandler Companies (Director · May 5, 2010 – Dec 13, 2019 · Past)
Director · Since at least Sep 1, 2019
R. John Fletcher
Other companies: KORU Medical Systems, Inc. (Director · Since at least May 7, 2019); OptiNose (Director · Apr 26, 2022 – May 21, 2025 · Past); Vyant Bio Inc (Director · Mar 30, 2021 – Jan 17, 2023 · Past); Axcelis Technologies, Inc. (Director · May 15, 2019 – Feb 17, 2021 · Past)
Director · Since at least Mar 29, 2019
Marcio Souza
Other companies: Praxis Precision Medicines, Inc. (President & Chief Executive Officer · Since at least Oct 15, 2020); Spyre Therapeutics, Inc. (Director · Jun 18, 2021 – Aug 25, 2022 · Past); PTC Therapeutics, Inc. (Chief Operating Officer · May 31, 2017 – Feb 10, 2020 · Past)
Director · May 17, 2019 – May 17, 2019 · Past
Michael Pietrangelo
Other companies: Universal Insurance Holdings Inc (Director · Since at least Mar 26, 2010); Medicis Pharmaceutical Corp (Director · Sep 29, 2006 – Nov 30, 2012 · Past)
Director · Feb 27, 2012 – Jun 30, 2014 · Past
Charles E Koob
Other companies: MiMedx Group, Inc (Director · May 18, 2016 – Oct 2, 2020 · Past)
Director · Jun 30, 2015 – Oct 4, 2017 · Past
Lynnette C. Fallon
Other companies: Axcelis Technologies, Inc. (EXECUTIVE VP, HR/LEGAL · May 15, 2019 – Jan 3, 2025 · Past)
Director · Since at least Jul 15, 2021
Matthew B. Klein
Other companies: PTC Therapeutics, Inc. (Chief Executive Officer · Since at least Apr 21, 2026)
Director · Since at least May 19, 2026
Philip A Pizzo
Other companies: Global Blood Therapeutics Inc (Director · Sep 23, 2015 – Oct 5, 2022 · Past)
Director · Jun 30, 2015 – Oct 4, 2017 · Past
Bruce C ConwayDirector · Feb 27, 2012 – Mar 22, 2013 · Past
All 33 people
PersonSeat
Carol J BarbreVP Product Management · Feb 27, 2012 – Apr 13, 2012 · Past
Chris YelleyVice President of Strategic Operations · Since at least Nov 5, 2026
Danilo D'AlessandroChief Financial Officer · Since at least Sep 29, 2020
David W CarlsonChief Financial Officer · Feb 27, 2012 – Nov 5, 2013 · Past
Ernesto SalegioVice President, Segment Leader Translational & Pre-Clinical Research · Since at least Nov 5, 2026
Francis P GrilloCHIEF EXECUTIVE OFFICER, Director · Oct 4, 2017 – Nov 7, 2017 · Past
Harold A HurwitzChief Financial Officer · Aug 15, 2019 – Jul 9, 2020 · Past
Jacqueline KellerVice President of Marketing · Nov 13, 2024 – Nov 5, 2026 · Past
James K Malernee JrDirector · Feb 27, 2012 – Dec 31, 2013 · Past
Jeremy StigallChief Business Officer · Since at least May 13, 2022
Joseph M. BurnettCEO and President, Director · Since at least Nov 7, 2017
Kimble L JenkinsDirector · Feb 27, 2012 – Sep 30, 2020 · Past
Linda M. LiauDirector · Since at least Nov 2, 2021
Lyubomir ZagorchevVice President of Clinical Science & Applications · Since at least Nov 5, 2026
Mary McNamara-CullinaneVice President of Regulatory Affairs · Since at least Apr 20, 2026
Mazin SabraChief Operating Officer · Since at least Jan 22, 2026
Megan FaulkenberryVice President of Quality · Since at least Feb 12, 2025
Michael J RyanDirector · Jun 14, 2013 – Mar 31, 2015 · Past
Pascal E R GirinDirector · Since at least Sep 3, 2014
Paul LarsonChief Medical Officer · Since at least Sep 25, 2025
Rob KornSenior Vice President of Sales & Business Development · Since at least Nov 5, 2026
Timothy OrrVice President of Software Development · Since at least Nov 5, 2026
Timothy T. RichardsDirector · Since at least Apr 1, 2025

Open People

Log in to ask 6ix AI your own questions about ClearPoint Neuro Inc.